Islets of Langerhans | Pig | Argentina

1. Contact address(Person who provides information. This information will be treated confidentially)?

Title: MD

First Name: Andrea

Last Name: Grant

Address:

Zip:

State:

Country: New Zealand

Institution: Living Cell

Telephone: Technologies

Email:

2. What is the source of your information about human xenotransplantation practices?

Congress

3. What is the therapeutic purpose of this xenotransplantation treatment?

Diabetes

4. Where and when is this human xenotransplantation practice taking place?

Country: Argentina

Timing: in progress: 8patients

5. Is this treatment part of a clinical trial?

Yes

6. How many patients are included in this clinical trial?

8 patients

7. What are the inclusion criteria for patient selection?

i. Duration on the waiting list? No

ii. Life-threatening diseases without alternative therapy? No

iii. Is a protocol available? No

8. What is the animal source of the xenotransplantation product?

Pig

9.Source Animals
Do you have information about source animals?

No

10. Testing of safety
Do you have information about testing of safety?

No

11. What type of cells/tissues/organs was transplanted?

Cells: Islets of Langerhans

Tissues:

Organs:

Others:

12.What type of exposure to xenogeneic cells was involved?

  • Solid-organ Xenotransplantation: No
  • Cellular Xenotransplantation: Yes
  • Tissue Xenotransplantation: No
  • Human cells exposed to xenogeneic Feeder cells: No
  • Extracorporeal perfusion: No
  • Encapsulation: Yes
  • Other bioartificial isolation device:
  • Others:

13. Transplant
Do you have information about transplant recipients?

No

14. Have results been presented at a scientific congress?

Yes

if yes, where?
The joint congress of IXA and organ transplantation in ABO-incompatible and hyperimmunized recipient, 2013, Osaka, Japan

15. Have results been published in a scientific journal?

No

if yes, Where?

16. Is this human clinical trial performed with governmental and/or institutional oversight and supervision?

Yes

If yes, which?
Bioethical Committee of the Eva Peron Hospital.

17. Was the trial approved by a public health authorities(ministry of health, governmental agency…)?

Yes

if yes, which?
Minister of Health, Buenos Aires province

18.Was the trial overseen by a public health authorities(ministry of health, governmental agency…)?

Yes

if yes, which?
Minister of Health, Buenos Aires province

19. Comment

Tags:

Leave a Reply

Your email address will not be published. Required fields are marked *

*

code